SCHEMBL6999765

SCHEMBL6999765

CC1Oc2ccc(CCNCc3cccc(Cl)c3)cc2NC1=O

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.67
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
HDAC1 Q13547 1/20 0.46
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDR P35968 1/20 0.43
CHRM2 P08172 1/20 0.42
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
TAAR1 Q96RJ0 1/20 0.40
SMYD3 Q9H7B4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6996295 0.92 PARP1 (0.78) PARP1HDAC1TP53POLBSMN1; SMN2
SCHEMBL6305046 0.91 PARP1 (0.77) PARP1HDAC1TP53POLBSMN1; SMN2
SCHEMBL10262368 0.88 PARP1 (0.82) PARP1SMYD3
SCHEMBL6305288 0.84 PARP1 (0.88) PARP1TSHRTP53POLBSMN1; SMN2
SCHEMBL6302902 0.84 PARP1 (0.68) PARP1ALDH1A1TSHRTP53POLB
SCHEMBL6999731 0.82 PARP1 (0.80) PARP1ALDH1A1TSHRTP53POLB
SCHEMBL6304625 0.82 PARP1 (0.75) PARP1ALDH1A1TP53POLBSMN1; SMN2
SCHEMBL6310170 0.81 PARP1 (0.95) PARP1TP53POLBSMN1; SMN2SMYD3
SCHEMBL532477 0.81 PARP1 (1.00) PARP1TP53POLBSMN1; SMN2SMYD3
SCHEMBL7000465 0.81 PARP1 (0.67) PARP1ALDH1A1TSHRTP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed
EP-1015437-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 2000-07-05 EP disclosed
WO-1999012915-A1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AKTIENGESELLSCHAFT (DE) 1999-03-18 WO disclosed